Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer of the Company, is presenting at Rodman & Renshaw's 11th Annual Healthcare...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2009.Q2 2009 Summary --------------- - Finalized FDA...

- Second quarter financial results to be released July 29, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 20 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2009.Q1 2009 Summary ---------------- - Received tentative U.S....

- First quarter financial results to be released on May 13, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 7 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2008.Fiscal 2008 Summary -------------------...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for CIP-TRAMADOL ER, the Company's extended-release...

- Fourth quarter and year end financial results to be released on February 18, 2009 - Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, Feb. 9 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2008.Q3 2008 Summary --------------- - Entered into a...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it will now host its Q3 2008 conference call on Friday, November 7, 2008 at 10:00 a.m. (ET). Cipher invites all interested parties to...